| dc.identifier.citation | Adiwinata, R., Kristanto, A., Christianty, F., Richard, T., & Edbert, D. (2015). Tatalaksana Terkini Perlemakan Hati Non-Alkoholik, 2(1), 53–59. Ann, J., Eo, H., & Yunsook, L. (2015). Mulberry leaves ( Morus alba L .) ameliorate obesityinduced hepatic lipogenesis , fibrosis , and oxidative stress in high-fat diet-fed mice. Genes & Nutrition, 10(6), 1–13. https://doi.org/10.1007/s12263-015-0495-x Arab, J. P., Arrese, M., & Trauner, M. (2018). Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver Disease. Annu. Rev. Pathol. Mech. Dis, 13, 321–50. Retrieved from http;//doi. org/10.1146/annurev-pathol-020117-043617 Ayokanmi, O., & Akinloye, O. A. (2019). Oxidative Stress and Antioxidant Biomarkers in Clinical and Experimental Models of Non-Alcoholic. Medicina, 55(26). https://doi.org/10.3390/ medicina55020026 Buzzetti, E., Pinzani, M., & Tsochatzis, E. A. (2016). The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism, 65(8), 1038–1048. https://doi.org/10.1016/j. metabol.2015.12.012 Chan, E. W., Lye, P., & Wong, S. (2016). Phytochemistry , pharmacology , and clinical trials of Morus alba. Chinese Journal of Natural Medicines, 14(1), 17–30. https://doi.org/10.3724/ SP.J.1009.2016.00017 Cobbina, E., & Akhlaghi, F. (2017). Non-Alcoholic Fatty Liver Disease (NAFLD) - Pathogenesis, Classification, and Effect on Drug Metabolizing Enzymes and Transporters. Drug Metab Rev, 49(2), 197–211. https://doi.org/10.1080/03602532.2017.1293683.Non-Alcoholic Deeb, A., Attia, S., Mahmoud, S., Elhaj, G., & Elfatih, A. (2018). Dyslipidemia and Fatty Liver Disease in Overweight and Obese Children, 2018. https://doi.org/10.1155/2018/8626818 Iqbal, U., Perumpail, B. J., John, N., Sallam, S., Shah, N. D., Kwong, W., Ahmed, A. (2018). Judicious Use of Lipid Lowering Agents in the Management of NAFLD. Diseases, 6(87), 1–10. https://doi.org/10.3390/diseases6040087 Kasim, S., Arief, M., Sulaeman, A., & Widodo, J. (2012). Hubungan Obesitas dan Hipertrigliseridemia dengan Risiko Perlemakan Hati pada Pasien di Makassar Relationship between Obesity and Hypertriglyceridemia on Fatty Liver in Patients at Makassar, 1, 136–146. Katsiki, N., Mikhailidis, D. P., & Mantzoros, C. S. (2016). Non-alcoholic fatty liver disease and dyslipidemia: an update. Metabolism, 65(8), 1109–23. https://doi.org/10.1016/j. metabol.2016.05.003 Kobayashi, Y., Miyazawa, M., Araki, M., Kamei, A., Abe, K., Hiroi, T., … Kojima, T. (2016). Pharmacognosy & Natural Products Effects of Morus alba L . ( Mulberry ) Leaf Extract in Hypercholesterolemic Mice on Suppression of Cholesterol Synthesis. J Pharmacogn Nat Prod, 2(1), 1–9. https://doi.org/10.4172/2472-0992.1000113 Kutlu, O., Kaleli, H. N., & Ozer, E. (2018). Molecular Pathogenesis of Nonalcoholic Steatohepatitis- ( NASH- ) Related Hepatocellular Carcinoma, 2018. Lieber, C. S., Leo, M. A., Mak, K. M., Xu, Y., Cao, Q., Ren, C., Decarli, L. M. (2004). Model of non-alcoholic steatohepatitis. American Journal of Clinical Nutrition, 79(March 2018), 502–9. https://doi.org/10.1093/ajcn/79.3.502 Metwally, F. M., Ahmed, H. H., Rashad, H., & Zaazaa, A. M. (2016). Insights into the role of morus alba in reversing obesity-associated hepatic steatosis and related metabolic disorder in rats. Asian J Pharm Clin Res, 9(Supp 2), 231–8. Park, E., Lee, S., Lee, J., & Kim, J. (2012). Anti-inflammatory activity of mulberry leaf extract through inhibition of NF- j B. Journal of Functional Foods, 5(1), 178–186. https://doi. org/10.1016/j.jff.2012.10.002 Peng, C., Lin, H., Chung, D., Huang, C., & Wang, C. (2017). ScienceDirect Mulberry Leaf Extracts prevent obesity-induced NAFLD with regulating adipocytokines , inflammation and oxidative stress. Journal of Food and Drug Analysis, 26(2), 778–787. https://doi.org/10.1016/j. jfda.2017.10.008 Rodrigues, E. L., Marcelino, G., Silva, G. T., Figueiredo, P. S., Garcez, W. S., Corsino, J.,C, K. De. (2019). Nutraceutical and Medicinal Potential of the Morus Species in Metabolic Dysfunctions. https://doi.org/10.3390/ijms20020301 Syafitri, V., Arnelis, & Efrida. (2015). Artikel Penelitian Gambaran Profil Lipid Pasien Perlemakan Hati Non-Alkoholik. Jurnal Kesehatan Andalas, 4(1), 274–278. Xia, M., Bian, H., & Gao, X. (2019). NAFLD and Diabetes : Two Sides of the Same Coin ? Rationale for Gene-Based Personalized NAFLD Treatment, 10(August), 1–11. https://doi. org/10.3389/fphar.2019.00877 Yu, J., Marsh, S., Hu, J., Feng, W., & Wu, C. (2016). The Pathogenesis of Nonalcoholic Fatty Liver Disease : Interplay between Diet , Gut Microbiota , and Genetic Background, 2016. Zeni, A. L. B., & Molin, M. D. (2010). Artigo Hypotriglyceridemic effect of Morus alba L ., Moraceae , leaves in hyperlipidemic rats, 20(October 2008), 130–133. | id_ID |
